US Broker Ratings

Hologic, Inc. (HOLX) Stock Analysis: A Healthcare Powerhouse with an 8% Upside Potential

Hologic, Inc. (NASDAQ: HOLX) is a key player in the healthcare sector, specifically within the medical instruments and supplies industry. Known for its focus on women’s health, Hologic has established..

Biogen Inc. (BIIB) Stock Analysis: A Glimpse into the 32% Potential Upside

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, presents an intriguing proposition for investors, underscored by its promising therapies for neurological and neurodegenerative diseases. Based in Cambridge, Massachusetts,..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A Potential 37.78% Upside Sparks Investor Interest

Teva Pharmaceutical Industries (TEVA), a prominent player in the healthcare sector, is making waves among investors due to its substantial potential upside of 37.78%. Headquartered in Tel Aviv, Israel, Teva..

GE HealthCare Technologies Inc. (GEHC): Investor Outlook Reveals 23.69% Potential Upside Amid Robust Analyst Ratings

GE HealthCare Technologies Inc. (NYSE: GEHC), a heavyweight in the Health Information Services industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With a market capitalization..

Universal Health Services, Inc. (UHS) Stock Analysis: Navigating a Potential 18.32% Upside

Universal Health Services, Inc. (NYSE: UHS) is a notable player in the healthcare sector, with a strong foothold in the medical care facilities industry. Headquartered in King of Prussia, Pennsylvania,..

DexCom, Inc. (DXCM) Stock Analysis: Evaluating Growth Potential with a 14.74% Upside

DexCom, Inc. (NASDAQ: DXCM), a leader in the medical devices sector, has been capturing investor attention with its innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, DexCom..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 41.78% Potential Upside in the Healthcare Arena

Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the medical devices industry, is making headlines with its significant potential upside of 41.78% as indicated by the average target price..

Becton, Dickinson and Company (BDX): Investor Outlook on a 29% Potential Upside Amidst Strong Analyst Confidence

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture the attention of investors with its robust medical instruments and supplies business. With a market..

AstraZeneca PLC (AZN) Stock Analysis: Navigating a 15.59% Potential Upside Amid Robust Dividend Yield

AstraZeneca PLC (AZN), a leading biopharmaceutical giant based in Cambridge, United Kingdom, stands out in the healthcare sector with an impressive market capitalization of $225.8 billion. Known for its innovation..

Cencora, Inc. (COR): Investor Outlook Highlights 8.92% Potential Upside

Cencora, Inc. (COR), a prominent player in the healthcare sector specializing in medical distribution, is drawing considerable attention from investors. With its roots tracing back to 1871 and a recent..

Tenet Healthcare Corporation (THC) Stock Analysis: A Healthcare Giant with a 6.47% Upside Potential

Tenet Healthcare Corporation (NYSE: THC), a stalwart in the medical care facilities industry, offers investors a unique blend of stability and growth potential. Headquartered in Dallas, Texas, with a market..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 107% Upside Potential in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT), a biopharmaceutical leader based in Miami, Florida, has become a focal point for investors keen on the biotechnology sector. With a market capitalization of $13.53..

West Pharmaceutical Services, Inc. (WST) Investor Outlook: Exploring a 33.71% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a leading player in the healthcare sector, specializes in designing and manufacturing containment and delivery systems for injectable drugs and healthcare products. With a..

Edwards Lifesciences (EW) Stock Analysis: Navigating the Heart of the Medical Device Market with a 3.51% Upside

Edwards Lifesciences Corporation (NYSE: EW), a stalwart in the medical devices sector, stands as a beacon of innovation in the treatment of advanced cardiovascular diseases. With a robust market capitalization..

Novartis AG (NVS) Stock Analysis: Evaluating Earnings Growth Potential with a Strong Return on Equity

Novartis AG (NVS), a prominent player in the global healthcare sector, is a Swiss-based pharmaceutical giant renowned for its innovative drug manufacturing and robust research and development capabilities. With a..

GSK plc (GSK) Stock Analysis: Exploring Growth Potential with a Robust 3.90% Dividend Yield

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, stands as a major player within the drug manufacturers’ industry. Headquartered in London, the company has established a global footprint..

IDEXX Laboratories (IDXX) Stock Analysis: A Look at Its Robust 59.33% ROE Amidst Market Challenges

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector specializing in diagnostics and research, is captivating investor attention with its impressive return on equity (ROE) of 59.33%...

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Evaluating a 15.26% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK) stands as a formidable player in the healthcare sector, specifically within the drug manufacturers’ specialty & generic industry. As Japan’s largest pharmaceutical company, Takeda..

Johnson & Johnson (JNJ) Stock Analysis: A 9% Potential Upside Amid Strong Dividend Yield

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to be an appealing option for investors seeking stability and potential growth. With its current market capitalization standing..

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating Growth in a Competitive Healthcare Landscape

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable entity in the healthcare sector, commanding a market capitalization of $91.75 billion. As a major player in the medical care facilities..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds